We again observed a distinct cluster (Cluster 1) containing the majority of KRAS wildtype mPDAC (six of eight (75%); p = 3.0e–6) and cholangiocarcinoma (15/25 (60%); p = 6.4e–4) samples. The gene discussed is KRAS; the disease is cholangiocarcinoma.